There's a new player on the antibody-drug conjugate (ADC) scene. UK-based Pheon Therapeutics has entered stage right with $68 million in funding that will be used to fund development of a pipeline of ...

Today we have the second part of our Intel Mod Series - with the Intel nuc 9 Extreme. Today James runs some tests to modify ...

Requests to relocate abroad by Israelis working at multinational companies operating in Israel rose in the past year in ...

Barclays upgraded Vertiv Holdings Co. to “overweight” from “equal weight” on Friday, citing higher earnings estimates and a revised valuation following recent share price volatility.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...

The death of a prominent South Texas businessman and public servant is being investigated as a homicide, though few details ...

Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. The company develops a proprietary gene ...

President Donald Trump said he'll drop — for now — his push to deploy National Guard troops in Chicago, Los Angeles and ...

Frontera Energy's Colombian unit has signed a prepayment and commercial agreement worth up to $120 million with a unit of U.S ...

As LeBron James turns 41, an NBA coach and scouts assess his play, fit with Luka Dončić, defensive impact, and what comes ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

When Moussa Diabate is patrolling the paint, best believe he’ll stop at nothing to take what is his. The fourth-year ...